Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2Psoriasis 1Polycystic Ovary Syndrome 1Osteoarthritis 1Neoplasms 1Esophageal Neoplasms 1Cardiovascular Diseases 1Autoimmune Diseases 1Arthritis, Rheumatoid 1

Interventions

Social Determinants of Health 2Electrocardiography 2Echocardiography 2zanubrutinib 1sofosbuvir-velpatasvir drug combination 1ribociclib 1palbociclib 1acalabrutinib 1abemaciclib 1Vascular Stiffness 1Standard of Care 1Restraint, Physical 1Referral and Consultation 1Quality of Life 1Pulse Wave Analysis 1Practice Guidelines as Topic 1Positron-Emission Tomography 1Physical Conditioning, Human 1Patient Navigation 1Nutrition Assessment 1Methods 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1High-Intensity Interval Training 1Hematologic Tests 1Health Information Exchange 1Geritol 1Fish Oils 1Fatty Acids, Omega-3 1Ethanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiovascular Diseases × Fatty Acids, Omega-3 × 1 year × Clear all
NCT01169259 2025-11-06

VITAL

Brigham and Women's Hospital

Phase 3 Active not recruiting
25,871 enrolled 38 charts

Cardiovascular Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡